Trieu Vuonginsider trades

In SEC Form 4 filings, Trieu Vuong is listed as CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc. (OTLC). In the last 90 days, Trieu Vuong bought $23.5K of Oncotelic Therapeutics, Inc. (OTLC) on the open market and sold none. The largest purchase was $17.8K of Oncotelic Therapeutics, Inc. (OTLC) on Oct 29.

Companies and roles

Company	Role	Transactions	Last filed
OTLCOncotelic Therapeutics, Inc.	CHAIRMAN AND CEO	2	Oct 30

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-30

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
OTLCOncotelic Therapeutics, Inc.	Oct 29	Oct 30	P	1,044,990	$0.02	Purchase +$17,765	95,481,309	No	Form 4
OTLCOncotelic Therapeutics, Inc.	Oct 28	Oct 30	P	312,000	$0.02	Purchase +$5,772	94,436,319	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.